Skip to content Skip to navigation

The National Cancer Institute (NCI) has again awarded several five-year, Multi-institution grants in continued support of its Alliance for Nanotechnology in Cancer program

Friday, September 4, 2015
The National Cancer Institute (NCI) has again awarded several five-year, Multi-institution grants in continued support of its Alliance for Nanotechnology in Cancer program.  News Release
 
Given the progress to date of the Alliance, the NCI approved a third phase of the program with a sizable investment in funding. The Alliance program is dedicated to using nanotechnology solutions towards solving cancer biology and oncology problems as well as developing new cancer interventions based on nanotechnology. The program was established in 2004 and funds efforts at academic centers which are engaged in research and translation of new technologies to the clinical environment.
 
The third phase of the program will be composed of Centers of Cancer Nanotechnology Excellence (CCNE), Innovative Research in Cancer Nanotechnology (IRCN U01 grants), Cancer Nanotechnology Training Centers (CNTC), and the Nanotechnology Characterization Laboratory (NCL). Stanford won both CCNE (Gambhir and Wang, PIs) and CNTC (Rao and Felsher, PIs) for 2015-2020.